Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune ...

Biotest develops and markets immunoglobulins, coagulation factors and albumin based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. Biotest has more than ...

Biotest corrects forecast for revenue, cash flow and ROCE – EBIT guidance unchanged14-Nov-2024 / 08:56 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No ...

AMPLIFY-7P Phase 2 randomized study anticipated to complete enrollment in Q4 2024; formal interim analysis of disease-free survival ("DFS") expected in H1 2025Poster presentation at the Society for Im ...